Article(id=1329905482430525692, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905453393359761, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.05.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1722873600000, receivedDateStr=2024-08-06, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003775460, onlineDateStr=2026-11-18, pubDate=1746806400000, pubDateStr=2025-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003775460, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003775460, creator=13701087609, updateTime=1795003775460, updator=13701087609, issue=Issue{id=1329905453393359761, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='5', pageStart='567', pageEnd='701', issueExtLink='null', onlineDate='null', pubDate='1746806400000', pubDateStr='2025-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003768527, creator='13701087609', updateTime=1795004399576, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329908101827899966, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905453393359761, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329908101827899967, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905453393359761, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=567, endPage=575, ext={EN=ArticleExt(id=1329905482657018109, articleId=1329905482430525692, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Technological Progress of Regulation of Glycosylation Modification of Monoclonal Antibodies during Mammalian Cell Culture, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=

Biopharmaceuticals, especially therapeutic monoclonal antibodies(mAbs), are mainly produced in mammalian cell culture systems. Glycosylation is a critical quality attribute of mAbs, which has a significant impact on their biological activity, pharmacokinetics, half-life, and immunogenicity. Therefore, in order to better control the quality of glycosylation modification, the glycosylation process of mAbs must be regulated and monitored throughout the culture process of mammalian cells. This review focuses on the engineering of mammalian cells, optimization of cell culture processes and culture media, glycosylation regulators, mathematical models and omics technologies. And it introduces the technological progress achieved in the regulation of glycosylation modification of monoclonal antibodies during mammalian cell culture.

, authors=Lili ZHAO1, 2, Yuqiang ZHU1, 2, Hongtao WANG1, 2, Guimin ZHANG3, Zhong LIU3, *, authorsList=Lili ZHAO, Yuqiang ZHU, Hongtao WANG, Guimin ZHANG, Zhong LIU, authorCompany=null, correspAuthors=Zhong LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905482925453566, articleId=1329905482430525692, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=哺乳动物细胞培养过程中单克隆抗体的糖基化修饰调控技术进展, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=

生物制品,尤其是单克隆抗体药物,主要由哺乳动物细胞培养系统生产。糖基化是单克隆抗体药物的一个关键质量属性,对单克隆抗体的生物学活性、药代动力学、半衰期和免疫原性等有显著影响。因此,为了更好地控制糖基化修饰质量,必须在整个哺乳动物细胞的培养过程中对单克隆抗体的糖基化过程进行调控与监测。该文围绕哺乳动物细胞的工程改造、细胞培养工艺及培养基的优化、糖基化调节剂、数学模型和组学技术等方面内容,介绍哺乳细胞培养过程中单克隆抗体的糖基化修饰调控取得的技术进展。

, authors=赵丽丽1, 2, 朱玉强1, 2, 王宏涛1, 2, 张贵民3, 刘忠3, *, authorsList=赵丽丽, 朱玉强, 王宏涛, 张贵民, 刘忠, authorCompany=null, correspAuthors=刘忠, authorNote=

赵丽丽(1977—),女,博士,高级研究员,从事蛋白药物的研究。

, correspAuthorsNote=
刘忠(1975—),男,博士,高级研究员,从事蛋白药物的研究与开发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=uRkR5bm6v7s+UHMUKIqLAA==, magXml=Hxs7106cSETfgjxzwiHXZQ==, pdfUrl=null, pdf=fhW1axCqR7/9v54JZbE0mA==, pdfFileSize=1279592, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=bhacVXim4q8PRrduQsxOPQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329905483483296009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905483596542220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483483296009, language=EN, stringName=Lili ZHAO, firstName=Lili, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905483672039693, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483483296009, language=CN, stringName=赵丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.山东新时代药业有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio={"content":"

赵丽丽(1977—),女,博士,高级研究员,从事蛋白药物的研究。

"}, bioImg=null, bioContent=

赵丽丽(1977—),女,博士,高级研究员,从事蛋白药物的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905483755925775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905483860783378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483755925775, language=EN, stringName=Yuqiang ZHU, firstName=Yuqiang, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905483923697939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483755925775, language=CN, stringName=朱玉强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.山东新时代药业有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905483982418197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905484066304280, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483982418197, language=EN, stringName=Hongtao WANG, firstName=Hongtao, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905484129218841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483982418197, language=CN, stringName=王宏涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.山东新时代药业有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905484192133403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905484330545437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484192133403, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905484397654302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484192133403, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.鲁南制药集团股份有限公司,山东 临沂 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483378438405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=3., ext=[AuthorCompanyExt(id=1329905483395215622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905483407798535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])]), Author(id=1329905484464763168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=clevertree@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905484557037858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484464763168, language=EN, stringName=Zhong LIU, firstName=Zhong, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905484649312547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484464763168, language=CN, stringName=刘忠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.鲁南制药集团股份有限公司,山东 临沂 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483378438405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=3., ext=[AuthorCompanyExt(id=1329905483395215622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905483407798535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])])], keywords=[Keyword(id=1329905484754170148, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=1, keyword=mammalian cell), Keyword(id=1329905484812890405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=2, keyword=monoclonal antibody), Keyword(id=1329905484884193574, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=3, keyword=glycosylation modification), Keyword(id=1329905484947108135, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=4, keyword=cell culture), Keyword(id=1329905485014217000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=5, keyword=protein engineering), Keyword(id=1329905485081325865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=6, keyword=mathematical model), Keyword(id=1329905485144240426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=7, keyword=omics technology), Keyword(id=1329905485211349291, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=EN, orderNo=8, keyword=research progress), Keyword(id=1329905485274263852, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=1, keyword=哺乳动物细胞), Keyword(id=1329905485353955629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=2, keyword=单克隆抗体), Keyword(id=1329905485446230318, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=3, keyword=糖基化修饰), Keyword(id=1329905485517533487, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=4, keyword=细胞培养), Keyword(id=1329905485601419568, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=5, keyword=蛋白质工程), Keyword(id=1329905485693694257, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=6, keyword=数学模型), Keyword(id=1329905485748220210, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=7, keyword=组学技术), Keyword(id=1329905485815329075, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, language=CN, orderNo=8, keyword=研究进展)], refs=[Reference(id=1329905486016655669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MULLARD A.FDA approves 100th monoclonal antibody product [J].Nat Rev Drug Discov, 2021, 20(7): 491-495., articleTitle=null, refAbstract=null), Reference(id=1329905486087958838, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=WALSH G, WALSH E.Biopharmaceutical benchmarks 2022[J].Nat biotechnol, 2022, 40(12): 1722-1760., articleTitle=null, refAbstract=null), Reference(id=1329905486155067703, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=SHRIVASTAVA A, JOSHI S, GUTTMAN A, et al.N-Glycosylation of monoclonal antibody therapeutics: a comprehensive review on significance and characterization[J].Anal Chim Acta, 2022, 1209: 339828., articleTitle=null, refAbstract=null), Reference(id=1329905486209593656, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=CARILLO S, PÉREZ-ROBLES R, JAKES C, et al.Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies [J].J Pharm Anal, 2020, 10(1): 23-34., articleTitle=null, refAbstract=null), Reference(id=1329905486268313913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO S, ZHANG B L.Benchmark glycan profile of therapeutic monoclonal antibodies produced by mammalian cell expression systems [J].Pharm Res, 2024, 41(1): 29-37., articleTitle=null, refAbstract=null), Reference(id=1329905486335422778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG G, MADHAVARAO C N, MORRIS C, et al.Effects of process intensification on homogeneity of an IgG1: κ monoclonal antibody during perfusion culture [J].Appl Microbiol Biotechnol, 2024, 108(1): 274., articleTitle=null, refAbstract=null), Reference(id=1329905486394143035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO S, ZHANG B L.A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies [J].MAbs, 2024, 16(1): 2304268., articleTitle=null, refAbstract=null), Reference(id=1329905486478029116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=程速远, 赵 靖, 胡莹莹, 等.关于阿达木单抗生物类似药质量相似性评价要点的初步探讨[J].中国生物制品学杂志, 2021, 34(5): 626-632., articleTitle=null, refAbstract=null), Reference(id=1329905486540943677, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=EDWARDS E, LIVANOS M, KRUEGER A, et al.Strategies to control therapeutic antibody glycosylation during bioprocessing: synthesis and separation [J].Biotechnol Bioeng, 2022, 119(6): 1343-1358., articleTitle=null, refAbstract=null), Reference(id=1329905486595469630, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=DICKER M, STRASSER R.Using glyco-engineering to produce therapeutic proteins [J].Expert Opin Biol Ther,2015, 15(10): 1501-1516., articleTitle=null, refAbstract=null), Reference(id=1329905486658384191, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=SHARMAN J P, FARBER C M, MAHADEVAN D, et al.Ublituximab(TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial [J].Br J Haematol, 2017, 176(3): 412-420., articleTitle=null, refAbstract=null), Reference(id=1329905486742270272, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUNG C H, MIRAKHUR B, CHAN E, et al.Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose [J].N Engl J Med, 2008, 358(11): 1109-1117., articleTitle=null, refAbstract=null), Reference(id=1329905486809379137, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ILIEVA K M, FAZEKAS-SINGER J, BAX H J, et al.AllergoOncology: expression platform development and functional profiling of an anti-HER2 IgE antibody [J].Allergy, 2019, 74(10): 1985-1989., articleTitle=null, refAbstract=null), Reference(id=1329905486880682306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAN K F, SHAHREEL W, WAN C, et al.Inactivation of GDP-fucose transporter gene(Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies [J].Biotechnol J, 2016, 11(3): 399-414., articleTitle=null, refAbstract=null), Reference(id=1329905486947791171, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=LI W, ZHU Z Y, CHEN W Z, et al.Crystallizable fragment glycoengineering for therapeutic antibodies development [J].Front Immunol, 2017, 8: 1554., articleTitle=null, refAbstract=null), Reference(id=1329905487019094340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=GARCÍA-ALIJA M, VAN MOER B, SASTRE D E, et al.Modulating antibody effector functions by Fc glycoengineering[J].Biotechnol Adv, 2023, 67: 108201., articleTitle=null, refAbstract=null), Reference(id=1329905487073620293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=YAMANE-OHNUKI N, KINOSHITA S, INOUE-URAKUBO M, et al.Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity [J].Biotechnol Bioeng, 2004, 87(5): 614-622., articleTitle=null, refAbstract=null), Reference(id=1329905487140729158, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=MABASHI-ASAZUMA H, KUO C W, KHOO K H, et al.A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells [J].Glycobiology,2014, 24(3): 325-340., articleTitle=null, refAbstract=null), Reference(id=1329905487203643719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=VON HORSTEN H H, OGOREK C, BLANCHARD V, et al.Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase [J].Glycobiology, 2010, 20(12): 1607-1618., articleTitle=null, refAbstract=null), Reference(id=1329905487291724104, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=GOEDE V, FISCHER K, ENGELKE A, et al.Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study [J].Leukemia, 2015,29(7): 1602-1604., articleTitle=null, refAbstract=null), Reference(id=1329905487367221577, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=COSTA A R, RODRIGUES M E, HENRIQUES M, et al.Glycosylation: impact, control and improvement during therapeutic protein production [J].Crit Rev Biotechnol,2014, 34(4): 281-299., articleTitle=null, refAbstract=null), Reference(id=1329905487434330442, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUNG C Y, WANG Q, YANG S, et al.Combinatorial genome and protein engineering yields monoclonal antibodies with hypergalactosylation from CHO cells [J].Biotechnol Bioeng, 2017, 114(12): 2848-2856., articleTitle=null, refAbstract=null), Reference(id=1329905487514022219, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SURVE T, GADGIL M.Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: implications for use of alternate sugars [J].Biotechnol Prog, 2015, 31(2): 460-467., articleTitle=null, refAbstract=null), Reference(id=1329905487589519692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=BURLEIGH S C, VAN DE LAAR T, STROOP C J, et al.Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells [J].BMC Biotechnol,2011, 11(1): 95., articleTitle=null, refAbstract=null), Reference(id=1329905487648239949, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=WELLS E, SONG L Q, GREER M, et al.Media supplementation for targeted manipulation of monoclonal antibody galactosylation and fucosylation [J].Biotechnol Bioeng, 2020, 117(11): 3310-3321., articleTitle=null, refAbstract=null), Reference(id=1329905487719543118, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=NGUYEN DANG A, MUN M, ROSE C M, et al.Interaction of cell culture process parameters for modulating mAb afucosylation [J].Biotechnol Bioeng, 2019, 116(4): 831-845., articleTitle=null, refAbstract=null), Reference(id=1329905487795040591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=LOEBRICH S, CLARK E, LADD K, et al.Comprehensive manipulation of glycosylation profiles across development scales [J].MAbs, 2019, 11(2): 335-349., articleTitle=null, refAbstract=null), Reference(id=1329905487857955152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIANG A W, LI S Z, SPAHN P N, et al.Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology [J].Curr Opin Struct Biol, 2016, 40: 104-111., articleTitle=null, refAbstract=null), Reference(id=1329905487929258321, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=NMAGU D, SINGH S K, LEE K H.Creation of monoclonal antibody expressing CHO cell lines grown with sodium butyrate and characterization of resulting antibody glycosylation [J].Methods Enzymol, 2021, 660: 267-295., articleTitle=null, refAbstract=null), Reference(id=1329905487983784274, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=PRABHU A, GADRE R, GADGIL M.Zinc supplementation decreases galactosylation of recombinant IgG in CHO cells[J].Appl Microbiol Biotechnol, 2018, 102(14): 5989-5999., articleTitle=null, refAbstract=null), Reference(id=1329905488046698835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=VILLACRÉS C, TAYI V S, BUTLER M.Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies [J].J Biotechnol, 2021, 333: 49-62., articleTitle=null, refAbstract=null), Reference(id=1329905488109613396, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=EHRET J, ZIMMERMANN M, EICHHORN T, et al.Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells [J].Biotechnol Bioeng, 2019,116(4): 816-830., articleTitle=null, refAbstract=null), Reference(id=1329905488193499477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=YIN B J, WANG Q, CHUNG C Y, et al.A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells [J].Biotechnol Bioeng, 2017, 114(8): 1899-1902., articleTitle=null, refAbstract=null), Reference(id=1329905488264802646, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=RILLAHAN C D, ANTONOPOULOS A, LEFORT C T, et al.Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome [J].Nat Chem Biol, 2012, 8(7): 661-668., articleTitle=null, refAbstract=null), Reference(id=1329905488331911511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=RAMEEZ S, GOWTHAM Y K, NAYAR G, et al.Modulation of high mannose levels in N-linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar [J].Biotechnol Prog, 2021, 37(5): e3176., articleTitle=null, refAbstract=null), Reference(id=1329905488407408984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=BRANTLEY T J, MITCHELSON F G, KHATTAK S F.A class of low-cost alternatives to kifunensine for increasing high mannose N-linked glycosylation for monoclonal antibody production in Chinese hamster ovary cells [J].Biotechnol Prog, 2021, 37(1): e3076., articleTitle=null, refAbstract=null), Reference(id=1329905488474517849, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAHAM R J, BHATIA H, YOON S.Consequences of trace metal variability and supplementation on Chinese hamster ovary(CHO) cell culture performance: a review of key mechanisms and considerations [J].Biotechnol Bioeng,2019, 116(12): 3446-3456., articleTitle=null, refAbstract=null), Reference(id=1329905488554209626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=ST AMAND M M, RADHAKRISHNAN D, ROBINSON A S, et al.Identification of manipulated variables for a glycosylation control strategy [J].Biotechnol Bioeng, 2014,111(10): 1957-1970., articleTitle=null, refAbstract=null), Reference(id=1329905488629707099, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=KANG S, ZHANG Z Q, RICHARDSON J, et al.Metabolic markers associated with high mannose glycan levels of therapeutic recombinant monoclonal antibodies [J].J Biotechnol, 2015, 203: 22-31., articleTitle=null, refAbstract=null), Reference(id=1329905488717787484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=VILLIGER T K, STEINHOFF R F, IVARSSON M, et al.High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylation [J].J Biotechnol, 2016, 229: 3-12., articleTitle=null, refAbstract=null), Reference(id=1329905488801673565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=HOSSLER P, CHUMSAE C, RACICOT C, et al.Arabinosylation of recombinant human immunoglobulin-based protein therapeutics [J].MAbs, 2017, 9(4): 715-734., articleTitle=null, refAbstract=null), Reference(id=1329905488893948254, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=SYNOGROUND B F, MCGRAW C E, ELLIOTT K S, et al.Transient ammonia stress on Chinese hamster ovary(CHO)cells yield alterations to alanine metabolism and IgG glycosylation profiles [J].Biotechnol J, 2021, 16(7): e2100098., articleTitle=null, refAbstract=null), Reference(id=1329905488965251423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=SEO J S, MIN B S, KIM Y J, et al.Effect of glucose feeding on the glycosylation quality of antibody produced by a human cell line, F2N78, in fed-batch culture [J].Appl Microbiol Biotechnol, 2014, 98(8): 3509-3515., articleTitle=null, refAbstract=null), Reference(id=1329905489032360288, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=PATEL T P, PAREKH R B, MOELLERING B J, et al.Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody [J].Biochem J, 1992,285(Pt 3): 839-845., articleTitle=null, refAbstract=null), Reference(id=1329905489099469153, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=MASTRANGELI R, AUDINO M C, PALINSKY W, et al.The formidable challenge of controlling high mannose-type N-glycans in therapeutic mAbs [J].Trends Biotechnol, 2020,38(10): 1154-1168., articleTitle=null, refAbstract=null), Reference(id=1329905489174966626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=POWERS D N, TRUNFIO N, VELUGULA-YELLELA S R,et al.Multivariate data analysis of growth medium trends affecting antibody glycosylation [J].Biotechnol Prog, 2020,36(1): e2903., articleTitle=null, refAbstract=null), Reference(id=1329905489246269795, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=LEVANON S S, AHARONOVITZ O, MAOR-SHOSHANI A, et al.An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin [J].J Biotechnol, 2018, 276-277: 54-62., articleTitle=null, refAbstract=null), Reference(id=1329905489309184356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=ROMANN P, VUILLEMIN T, PAVONE S, et al.Maduramycin, a novel glycosylation modulator for mammalian fed-batch and steady-state perfusion processes[J].J Biotechnol, 2024, 383: 73-85., articleTitle=null, refAbstract=null), Reference(id=1329905489380487525, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG L, SCHWARZ H, WANG M L, et al.Control of IgG glycosylation in CHO cell perfusion cultures by GReBA mathematical model supported by a novel targeted feed, TAFE[J].Metab Eng, 2021, 65: 135-145., articleTitle=null, refAbstract=null), Reference(id=1329905489451790694, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=MARSCHALL L, GOTTIMUKKALA C B.Temperature upshifts in mammalian cell culture: a suitable strategy for biosimilar monoclonal antibodies? [J].Bioengineering(Basel), 2023, 10(10): 1149., articleTitle=null, refAbstract=null), Reference(id=1329905489518899559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=BATRA J, RATHORE A S.Glycosylation of monoclonal antibody products: current status and future prospects [J].Biotechnol Prog, 2016, 32(5): 1091-1102., articleTitle=null, refAbstract=null), Reference(id=1329905489586008424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=RISH A J, SIDDIQUEE K, HUANG Z R, et al.Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing [J].Biotechnol J, 2023, 18(7): e2200604., articleTitle=null, refAbstract=null), Reference(id=1329905489648922985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=陈孝欢, 孙瑞强.pH和pCO2对抗体五聚甘露糖修饰水平的影响研究[J].生物化工, 2023, 9(5): 78-85., articleTitle=null, refAbstract=null), Reference(id=1329905489728614762, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=HOSSLER P, KHATTAK S F, LI Z J.Optimal and consistent protein glycosylation in mammalian cell culture [J].Glycobiology, 2009, 19(9): 936-949., articleTitle=null, refAbstract=null), Reference(id=1329905489820889451, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=GUPTA S K, SHUKLA P.Glycosylation control technologies for recombinant therapeutic proteins [J].Appl Microbiol Biotechnol, 2018, 102(24): 10457-10468., articleTitle=null, refAbstract=null), Reference(id=1329905489887998316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUNG S, TIAN J, TAN Z J, et al.Modulating cell culture oxidative stress reduces protein glycation and acidic charge variant formation [J].MAbs, 2019, 11(1): 205-216., articleTitle=null, refAbstract=null), Reference(id=1329905489976078701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=W EYSTER T, TALWAR S, FERNANDEZ J, et al.Tuning monoclonal antibody galactosylation using Raman spectroscopy-controlled lactic acid feeding [J].Biotechnol Prog, 2021, 37(1): e3085., articleTitle=null, refAbstract=null), Reference(id=1329905490038993262, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=REDDY J V, RAUDENBUSH K, PAPOUTSAKIS E T, et al.Cell-culture process optimization via model-based predictions of metabolism and protein glycosylation [J].Biotechnol Adv,2023, 67: 108179., articleTitle=null, refAbstract=null), Reference(id=1329905490106102127, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=KOTIDIS P, JEDRZEJEWSKI P, SOU S N, et al.Model-based optimization of antibody galactosylation in CHO cell culture [J].Biotechnol Bioeng, 2019, 116(7): 1612-1626., articleTitle=null, refAbstract=null), Reference(id=1329905490169016688, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=BARLAN K, BHIDE G P, WHITE D R, et al.Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells [J].SLAS Discov, 2024, 29(1): 52-58., articleTitle=null, refAbstract=null), Reference(id=1329905490244514161, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=SUMIT M, DOLATSHAHI S, CHU A A, et al.Dissecting N-glycosylation dynamics in Chinese hamster ovary cells fed-batch cultures using time course omics analyses [J].iScience, 2019, 12: 102-120., articleTitle=null, refAbstract=null), Reference(id=1329905490324205938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE A P, KOK Y J, LAKSHMANAN M, et al.Multi-omics profiling of a CHO cell culture system unravels the effect of culture pH on cell growth, antibody titer, and product quality[J].Biotechnol Bioeng, 2021, 118(11): 4305-4316., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329905485907603764, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, awardId=tscy202306088; tscy20200329, language=CN, fundingSource=山东省重点研发计划(泰山产业领军人才工程)项目(tscy202306088; tscy20200329), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)]), AuthorCompany(id=1329905483378438405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=3., ext=[AuthorCompanyExt(id=1329905483395215622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905483407798535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.05.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.05.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.05.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.05.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1746806400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
哺乳动物细胞培养过程中单克隆抗体的糖基化修饰调控技术进展
赵丽丽 1, 2 , 朱玉强 1, 2 , 王宏涛 1, 2 , 张贵民 3 , 刘忠 3, *
中国医药工业杂志 | 专论与综述 2025,56(5): 567-575
收起
收藏切换
中国医药工业杂志 |专论与综述 2025 , 56 (5) : 567 -575
哺乳动物细胞培养过程中单克隆抗体的糖基化修饰调控技术进展
全屏
[Author(id=1329905483483296009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905483596542220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483483296009, language=EN, stringName=Lili ZHAO, firstName=Lili, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905483672039693, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483483296009, language=CN, stringName=赵丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.山东新时代药业有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio={"content":"

赵丽丽(1977—),女,博士,高级研究员,从事蛋白药物的研究。

"}, bioImg=null, bioContent=

赵丽丽(1977—),女,博士,高级研究员,从事蛋白药物的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905483755925775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905483860783378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483755925775, language=EN, stringName=Yuqiang ZHU, firstName=Yuqiang, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905483923697939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483755925775, language=CN, stringName=朱玉强, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.山东新时代药业有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905483982418197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905484066304280, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483982418197, language=EN, stringName=Hongtao WANG, firstName=Hongtao, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905484129218841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905483982418197, language=CN, stringName=王宏涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.山东新时代药业有限公司,山东 临沂 273400
2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483177111807, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=1., ext=[AuthorCompanyExt(id=1329905483198083328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1329905483206471937, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483177111807, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.山东新时代药业有限公司,山东 临沂 273400)]), AuthorCompany(id=1329905483281969410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=2., ext=[AuthorCompanyExt(id=1329905483290358019, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400), AuthorCompanyExt(id=1329905483298746628, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483281969410, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400)])]), Author(id=1329905484192133403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905484330545437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484192133403, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905484397654302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484192133403, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.鲁南制药集团股份有限公司,山东 临沂 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483378438405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=3., ext=[AuthorCompanyExt(id=1329905483395215622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905483407798535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])]), Author(id=1329905484464763168, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=clevertree@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905484557037858, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484464763168, language=EN, stringName=Zhong LIU, firstName=Zhong, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905484649312547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, authorId=1329905484464763168, language=CN, stringName=刘忠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.鲁南制药集团股份有限公司,山东 临沂 276000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905483378438405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, xref=3., ext=[AuthorCompanyExt(id=1329905483395215622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000), AuthorCompanyExt(id=1329905483407798535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905482430525692, companyId=1329905483378438405, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.鲁南制药集团股份有限公司,山东 临沂 276000)])])]
赵丽丽1, 2, 朱玉强1, 2, 王宏涛1, 2, 张贵民3, 刘忠3, *
作者信息
  • 1.山东新时代药业有限公司,山东 临沂 273400
  • 2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400
  • 3.鲁南制药集团股份有限公司,山东 临沂 276000
通讯作者:
刘忠(1975—),男,博士,高级研究员,从事蛋白药物的研究与开发。E-mail:
作者简介:

赵丽丽(1977—),女,博士,高级研究员,从事蛋白药物的研究。

Technological Progress of Regulation of Glycosylation Modification of Monoclonal Antibodies during Mammalian Cell Culture
Lili ZHAO1, 2, Yuqiang ZHU1, 2, Hongtao WANG1, 2, Guimin ZHANG3, Zhong LIU3, *
Affiliations
  • 1.Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400
  • 2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
  • 3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
出版时间: 2025-05-10 doi: 10.16522/j.cnki.cjph.2025.05.001
文章导航
收藏切换

生物制品,尤其是单克隆抗体药物,主要由哺乳动物细胞培养系统生产。糖基化是单克隆抗体药物的一个关键质量属性,对单克隆抗体的生物学活性、药代动力学、半衰期和免疫原性等有显著影响。因此,为了更好地控制糖基化修饰质量,必须在整个哺乳动物细胞的培养过程中对单克隆抗体的糖基化过程进行调控与监测。该文围绕哺乳动物细胞的工程改造、细胞培养工艺及培养基的优化、糖基化调节剂、数学模型和组学技术等方面内容,介绍哺乳细胞培养过程中单克隆抗体的糖基化修饰调控取得的技术进展。

哺乳动物细胞  /  单克隆抗体  /  糖基化修饰  /  细胞培养  /  蛋白质工程  /  数学模型  /  组学技术  /  研究进展

Biopharmaceuticals, especially therapeutic monoclonal antibodies(mAbs), are mainly produced in mammalian cell culture systems. Glycosylation is a critical quality attribute of mAbs, which has a significant impact on their biological activity, pharmacokinetics, half-life, and immunogenicity. Therefore, in order to better control the quality of glycosylation modification, the glycosylation process of mAbs must be regulated and monitored throughout the culture process of mammalian cells. This review focuses on the engineering of mammalian cells, optimization of cell culture processes and culture media, glycosylation regulators, mathematical models and omics technologies. And it introduces the technological progress achieved in the regulation of glycosylation modification of monoclonal antibodies during mammalian cell culture.

mammalian cell  /  monoclonal antibody  /  glycosylation modification  /  cell culture  /  protein engineering  /  mathematical model  /  omics technology  /  research progress
赵丽丽, 朱玉强, 王宏涛, 张贵民, 刘忠. 哺乳动物细胞培养过程中单克隆抗体的糖基化修饰调控技术进展. 中国医药工业杂志, 2025 , 56 (5) : 567 -575 . DOI: 10.16522/j.cnki.cjph.2025.05.001
Lili ZHAO, Yuqiang ZHU, Hongtao WANG, Guimin ZHANG, Zhong LIU. Technological Progress of Regulation of Glycosylation Modification of Monoclonal Antibodies during Mammalian Cell Culture[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (5) : 567 -575 . DOI: 10.16522/j.cnki.cjph.2025.05.001
  • 山东省重点研发计划(泰山产业领军人才工程)项目(tscy202306088; tscy20200329)
参考文献 引证文献
排序方式:
[1]
MULLARD A.FDA approves 100th monoclonal antibody product [J].Nat Rev Drug Discov, 2021, 20(7): 491-495.
[2]
WALSH G, WALSH E.Biopharmaceutical benchmarks 2022[J].Nat biotechnol, 2022, 40(12): 1722-1760.
[3]
SHRIVASTAVA A, JOSHI S, GUTTMAN A, et al.N-Glycosylation of monoclonal antibody therapeutics: a comprehensive review on significance and characterization[J].Anal Chim Acta, 2022, 1209: 339828.
[4]
CARILLO S, PÉREZ-ROBLES R, JAKES C, et al.Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies [J].J Pharm Anal, 2020, 10(1): 23-34.
[5]
LUO S, ZHANG B L.Benchmark glycan profile of therapeutic monoclonal antibodies produced by mammalian cell expression systems [J].Pharm Res, 2024, 41(1): 29-37.
[6]
LIANG G, MADHAVARAO C N, MORRIS C, et al.Effects of process intensification on homogeneity of an IgG1: κ monoclonal antibody during perfusion culture [J].Appl Microbiol Biotechnol, 2024, 108(1): 274.
[7]
LUO S, ZHANG B L.A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies [J].MAbs, 2024, 16(1): 2304268.
[8]
程速远, 赵 靖, 胡莹莹, 等.关于阿达木单抗生物类似药质量相似性评价要点的初步探讨[J].中国生物制品学杂志, 2021, 34(5): 626-632.
[9]
EDWARDS E, LIVANOS M, KRUEGER A, et al.Strategies to control therapeutic antibody glycosylation during bioprocessing: synthesis and separation [J].Biotechnol Bioeng, 2022, 119(6): 1343-1358.
[10]
DICKER M, STRASSER R.Using glyco-engineering to produce therapeutic proteins [J].Expert Opin Biol Ther,2015, 15(10): 1501-1516.
[11]
SHARMAN J P, FARBER C M, MAHADEVAN D, et al.Ublituximab(TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial [J].Br J Haematol, 2017, 176(3): 412-420.
[12]
CHUNG C H, MIRAKHUR B, CHAN E, et al.Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose [J].N Engl J Med, 2008, 358(11): 1109-1117.
[13]
ILIEVA K M, FAZEKAS-SINGER J, BAX H J, et al.AllergoOncology: expression platform development and functional profiling of an anti-HER2 IgE antibody [J].Allergy, 2019, 74(10): 1985-1989.
[14]
CHAN K F, SHAHREEL W, WAN C, et al.Inactivation of GDP-fucose transporter gene(Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies [J].Biotechnol J, 2016, 11(3): 399-414.
[15]
LI W, ZHU Z Y, CHEN W Z, et al.Crystallizable fragment glycoengineering for therapeutic antibodies development [J].Front Immunol, 2017, 8: 1554.
[16]
GARCÍA-ALIJA M, VAN MOER B, SASTRE D E, et al.Modulating antibody effector functions by Fc glycoengineering[J].Biotechnol Adv, 2023, 67: 108201.
[17]
YAMANE-OHNUKI N, KINOSHITA S, INOUE-URAKUBO M, et al.Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity [J].Biotechnol Bioeng, 2004, 87(5): 614-622.
[18]
MABASHI-ASAZUMA H, KUO C W, KHOO K H, et al.A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells [J].Glycobiology,2014, 24(3): 325-340.
[19]
VON HORSTEN H H, OGOREK C, BLANCHARD V, et al.Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase [J].Glycobiology, 2010, 20(12): 1607-1618.
[20]
GOEDE V, FISCHER K, ENGELKE A, et al.Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study [J].Leukemia, 2015,29(7): 1602-1604.
[21]
COSTA A R, RODRIGUES M E, HENRIQUES M, et al.Glycosylation: impact, control and improvement during therapeutic protein production [J].Crit Rev Biotechnol,2014, 34(4): 281-299.
[22]
CHUNG C Y, WANG Q, YANG S, et al.Combinatorial genome and protein engineering yields monoclonal antibodies with hypergalactosylation from CHO cells [J].Biotechnol Bioeng, 2017, 114(12): 2848-2856.
[23]
SURVE T, GADGIL M.Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: implications for use of alternate sugars [J].Biotechnol Prog, 2015, 31(2): 460-467.
[24]
BURLEIGH S C, VAN DE LAAR T, STROOP C J, et al.Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells [J].BMC Biotechnol,2011, 11(1): 95.
[25]
WELLS E, SONG L Q, GREER M, et al.Media supplementation for targeted manipulation of monoclonal antibody galactosylation and fucosylation [J].Biotechnol Bioeng, 2020, 117(11): 3310-3321.
[26]
NGUYEN DANG A, MUN M, ROSE C M, et al.Interaction of cell culture process parameters for modulating mAb afucosylation [J].Biotechnol Bioeng, 2019, 116(4): 831-845.
[27]
LOEBRICH S, CLARK E, LADD K, et al.Comprehensive manipulation of glycosylation profiles across development scales [J].MAbs, 2019, 11(2): 335-349.
[28]
CHIANG A W, LI S Z, SPAHN P N, et al.Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology [J].Curr Opin Struct Biol, 2016, 40: 104-111.
[29]
NMAGU D, SINGH S K, LEE K H.Creation of monoclonal antibody expressing CHO cell lines grown with sodium butyrate and characterization of resulting antibody glycosylation [J].Methods Enzymol, 2021, 660: 267-295.
[30]
PRABHU A, GADRE R, GADGIL M.Zinc supplementation decreases galactosylation of recombinant IgG in CHO cells[J].Appl Microbiol Biotechnol, 2018, 102(14): 5989-5999.
[31]
VILLACRÉS C, TAYI V S, BUTLER M.Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies [J].J Biotechnol, 2021, 333: 49-62.
[32]
EHRET J, ZIMMERMANN M, EICHHORN T, et al.Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells [J].Biotechnol Bioeng, 2019,116(4): 816-830.
[33]
YIN B J, WANG Q, CHUNG C Y, et al.A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells [J].Biotechnol Bioeng, 2017, 114(8): 1899-1902.
[34]
RILLAHAN C D, ANTONOPOULOS A, LEFORT C T, et al.Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome [J].Nat Chem Biol, 2012, 8(7): 661-668.
[35]
RAMEEZ S, GOWTHAM Y K, NAYAR G, et al.Modulation of high mannose levels in N-linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar [J].Biotechnol Prog, 2021, 37(5): e3176.
[36]
BRANTLEY T J, MITCHELSON F G, KHATTAK S F.A class of low-cost alternatives to kifunensine for increasing high mannose N-linked glycosylation for monoclonal antibody production in Chinese hamster ovary cells [J].Biotechnol Prog, 2021, 37(1): e3076.
[37]
GRAHAM R J, BHATIA H, YOON S.Consequences of trace metal variability and supplementation on Chinese hamster ovary(CHO) cell culture performance: a review of key mechanisms and considerations [J].Biotechnol Bioeng,2019, 116(12): 3446-3456.
[38]
ST AMAND M M, RADHAKRISHNAN D, ROBINSON A S, et al.Identification of manipulated variables for a glycosylation control strategy [J].Biotechnol Bioeng, 2014,111(10): 1957-1970.
[39]
KANG S, ZHANG Z Q, RICHARDSON J, et al.Metabolic markers associated with high mannose glycan levels of therapeutic recombinant monoclonal antibodies [J].J Biotechnol, 2015, 203: 22-31.
[40]
VILLIGER T K, STEINHOFF R F, IVARSSON M, et al.High-throughput profiling of nucleotides and nucleotide sugars to evaluate their impact on antibody N-glycosylation [J].J Biotechnol, 2016, 229: 3-12.
[41]
HOSSLER P, CHUMSAE C, RACICOT C, et al.Arabinosylation of recombinant human immunoglobulin-based protein therapeutics [J].MAbs, 2017, 9(4): 715-734.
[42]
SYNOGROUND B F, MCGRAW C E, ELLIOTT K S, et al.Transient ammonia stress on Chinese hamster ovary(CHO)cells yield alterations to alanine metabolism and IgG glycosylation profiles [J].Biotechnol J, 2021, 16(7): e2100098.
[43]
SEO J S, MIN B S, KIM Y J, et al.Effect of glucose feeding on the glycosylation quality of antibody produced by a human cell line, F2N78, in fed-batch culture [J].Appl Microbiol Biotechnol, 2014, 98(8): 3509-3515.
[44]
PATEL T P, PAREKH R B, MOELLERING B J, et al.Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody [J].Biochem J, 1992,285(Pt 3): 839-845.
[45]
MASTRANGELI R, AUDINO M C, PALINSKY W, et al.The formidable challenge of controlling high mannose-type N-glycans in therapeutic mAbs [J].Trends Biotechnol, 2020,38(10): 1154-1168.
[46]
POWERS D N, TRUNFIO N, VELUGULA-YELLELA S R,et al.Multivariate data analysis of growth medium trends affecting antibody glycosylation [J].Biotechnol Prog, 2020,36(1): e2903.
[47]
LEVANON S S, AHARONOVITZ O, MAOR-SHOSHANI A, et al.An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin [J].J Biotechnol, 2018, 276-277: 54-62.
[48]
ROMANN P, VUILLEMIN T, PAVONE S, et al.Maduramycin, a novel glycosylation modulator for mammalian fed-batch and steady-state perfusion processes[J].J Biotechnol, 2024, 383: 73-85.
[49]
ZHANG L, SCHWARZ H, WANG M L, et al.Control of IgG glycosylation in CHO cell perfusion cultures by GReBA mathematical model supported by a novel targeted feed, TAFE[J].Metab Eng, 2021, 65: 135-145.
[50]
MARSCHALL L, GOTTIMUKKALA C B.Temperature upshifts in mammalian cell culture: a suitable strategy for biosimilar monoclonal antibodies? [J].Bioengineering(Basel), 2023, 10(10): 1149.
[51]
BATRA J, RATHORE A S.Glycosylation of monoclonal antibody products: current status and future prospects [J].Biotechnol Prog, 2016, 32(5): 1091-1102.
[52]
RISH A J, SIDDIQUEE K, HUANG Z R, et al.Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing [J].Biotechnol J, 2023, 18(7): e2200604.
[53]
陈孝欢, 孙瑞强.pH和pCO2对抗体五聚甘露糖修饰水平的影响研究[J].生物化工, 2023, 9(5): 78-85.
[54]
HOSSLER P, KHATTAK S F, LI Z J.Optimal and consistent protein glycosylation in mammalian cell culture [J].Glycobiology, 2009, 19(9): 936-949.
[55]
GUPTA S K, SHUKLA P.Glycosylation control technologies for recombinant therapeutic proteins [J].Appl Microbiol Biotechnol, 2018, 102(24): 10457-10468.
[56]
CHUNG S, TIAN J, TAN Z J, et al.Modulating cell culture oxidative stress reduces protein glycation and acidic charge variant formation [J].MAbs, 2019, 11(1): 205-216.
[57]
W EYSTER T, TALWAR S, FERNANDEZ J, et al.Tuning monoclonal antibody galactosylation using Raman spectroscopy-controlled lactic acid feeding [J].Biotechnol Prog, 2021, 37(1): e3085.
[58]
REDDY J V, RAUDENBUSH K, PAPOUTSAKIS E T, et al.Cell-culture process optimization via model-based predictions of metabolism and protein glycosylation [J].Biotechnol Adv,2023, 67: 108179.
[59]
KOTIDIS P, JEDRZEJEWSKI P, SOU S N, et al.Model-based optimization of antibody galactosylation in CHO cell culture [J].Biotechnol Bioeng, 2019, 116(7): 1612-1626.
[60]
BARLAN K, BHIDE G P, WHITE D R, et al.Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells [J].SLAS Discov, 2024, 29(1): 52-58.
[61]
SUMIT M, DOLATSHAHI S, CHU A A, et al.Dissecting N-glycosylation dynamics in Chinese hamster ovary cells fed-batch cultures using time course omics analyses [J].iScience, 2019, 12: 102-120.
[62]
LEE A P, KOK Y J, LAKSHMANAN M, et al.Multi-omics profiling of a CHO cell culture system unravels the effect of culture pH on cell growth, antibody titer, and product quality[J].Biotechnol Bioeng, 2021, 118(11): 4305-4316.
2025年第56卷第5期
38
10
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.05.001
  • 接收时间:2024-08-06
  • 首发时间:2026-11-18
  • 出版时间:2025-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-08-06
基金
山东省重点研发计划(泰山产业领军人才工程)项目(tscy202306088; tscy20200329)
作者信息
    1.山东新时代药业有限公司,山东 临沂 273400
    2.哺乳动物细胞高效表达国家工程实验室,山东 临沂 273400
    3.鲁南制药集团股份有限公司,山东 临沂 276000

通讯作者:

刘忠(1975—),男,博士,高级研究员,从事蛋白药物的研究与开发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.05.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏